Vir Biotechnology, Inc. announced on April 15, 2024, Sung Lee, executive vice president of the company informed the company that he will be stepping down from his role, effective May 3, 2024, to pursue another career opportunity.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.23 USD | -6.30% | +9.35% | +11.63% |
Jun. 06 | Morgan Stanley Adjusts Price Target on Vir Biotechnology to $15 From $12, Maintains Equal-Weight Rating | MT |
Jun. 05 | Sector Update: Health Care Stocks Steady Premarket Wednesday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.63% | 1.53B | |
+51.85% | 57.87B | |
+41.70% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology, Inc. Announces Stepping Down of Sung Lee as Executive Vice President, effective May 3, 2024